Marketing & Business Development Appointment

RNS Number : 9455E

CareCapital Group plc

08 June 2012

 



8 June 2012

CARECAPITAL GROUP PLC

("CareCapital" or "the Company")

Appointment of Director of Marketing and Business Development

Karen Bullivant to join cancer treatment services team

CareCapital (AIM: CARE) is pleased to announce the appointment of Ms Karen Bullivant as Director of Marketing and Business Development effective full time from 1 January 2013, but part time with immediate effect.  A non-Board appointment, Karen joins the team at CareCapital responsible for developing and growing the Company's cancer treatment services business.

Karen's career in strategic marketing, branding and new business development in healthcare has included working in the United States, the Middle East and Europe. She worked for Pfizer in the USA before moving to London in 2001.  In the UK, she initially worked for the specialist healthcare division of Young & Rubicam before moving to Bupa where she focused on creating customised marketing solutions that achieved commercial results while retaining goals that were centred on customer and patient needs.  In 2005, Karen joined The London Clinic as Marketing Director where she most recently launched its £90 million cancer centre with an integrated B2C and B2B campaign. Karen holds a BA in Philosophy and an MBA in Marketing.

Karen has been a Trustee of the University College London Cancer Trust since 2010 and has most recently focused, in this pro bono role, on fundraising for translational research which will create targeted and patient-tailored therapies. These new advances will someday enable clinicians to stratify patients based on the genetic profile of their individual tumours and to predict what treatment combinations will give the best patient outcome with the lowest side effects.

Commenting on the appointment, Dr Mike Sinclair, CareCapital's CEO, said, "We are delighted that Karen has agreed to join us.  Her experience and expertise in helping to position and grow major healthcare businesses will be invaluable as we build CareCapital's cancer treatment services activities.  The time Karen has spent on both sides of the agency/client divide will also help us to get the best out of our marketing advisory relationships. I welcome her to the team."

For further information, please visit www.carecapital.co.uk or contact:

Michael Sinclair, CEO	Simon Hudson / Kelsey Traynor
CareCapital Group Plc	Tavistock Communications (Financial PR & IR)
020 3617 8727	020 7920 3150

About CareCapital

CareCapital recently announced a restructuring to reflect its strategy to reposition the Company primarily as an investor in, and provider of, advanced cancer treatments.  Current investments in medical centre development projects are to be transferred to the Company's wholly owned subsidiary - The Healthcare Property Company Limited - which will continue to progress existing schemes and expand through securing new medical centre projects in the UK.  This company will also provide property related support services to the wider CareCapital group. The Company also announced that it will be seeking shareholder authority at the earliest opportunity to change its name to Advanced Oncotherapy plc.

CareCapital is building a portfolio of innovative cancer treatment services to capture opportunities in the cancer diagnosis and treatment market, building on its 28.75% stake in Advanced Proton Solutions (Holdings) Ltd and its newly launched Oncotherapy Resources business focused on early stage breast cancer treatment.  Advanced Proton Solutions is pioneering the use of Proton Beam Therapy in the UK and which has secured planning approval for its first London based centre off Moorgate in the City of London, within easy access of a number of London's major hospitals.

CareCapital also specialises, as an innovative developer, in primary care real estate, particularly multi-occupancy premises that accommodate a variety of different, but often synergetic healthcare providers. This is particularly relevant at a time when the Government is intent on expanding primary care, bringing more services together under one roof and closer to patients in their own communities.  Working in partnership with local authorities, projects can involve significant urban regeneration, with mixed-use and mixed-economy developments incorporating housing, healthcare, childcare, retail and other appropriate facilities for the community.

-ends-

 

END

 

 

NRASSWFMWFESEDM